Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:beractant'
(id=6891607 ; fe=en:beractant ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=9716.619995117188 creation date=2017-06-25 touchdate=2025-08-31 22:49:36.000)
≈ 250 relations sortantes

  1. en:beractant -- r_associated #0: 43 / 1 -> en:tasuldine
    n1=en:beractant | n2=en:tasuldine | rel=r_associated | relid=0 | w=43
  2. en:beractant -- r_associated #0: 40 / 0.93 -> en:fudosteine
    n1=en:beractant | n2=en:fudosteine | rel=r_associated | relid=0 | w=40
  3. en:beractant -- r_associated #0: 39 / 0.907 -> en:immunotoxin
    n1=en:beractant | n2=en:immunotoxin | rel=r_associated | relid=0 | w=39
  4. en:beractant -- r_associated #0: 37 / 0.86 -> en:biological warfare agents
    n1=en:beractant | n2=en:biological warfare agents | rel=r_associated | relid=0 | w=37
  5. en:beractant -- r_associated #0: 35 / 0.814 -> en:acetylcysteine
    n1=en:beractant | n2=en:acetylcysteine | rel=r_associated | relid=0 | w=35
  6. en:beractant -- r_associated #0: 35 / 0.814 -> en:biological control agents
    n1=en:beractant | n2=en:biological control agents | rel=r_associated | relid=0 | w=35
  7. en:beractant -- r_associated #0: 35 / 0.814 -> en:luspatercept
    n1=en:beractant | n2=en:luspatercept | rel=r_associated | relid=0 | w=35
  8. en:beractant -- r_associated #0: 35 / 0.814 -> en:vaccine
    n1=en:beractant | n2=en:vaccine | rel=r_associated | relid=0 | w=35
  9. en:beractant -- r_associated #0: 34 / 0.791 -> en:autologous cd34-positive hematopoietic progenitor cells
    n1=en:beractant | n2=en:autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=34
  10. en:beractant -- r_associated #0: 34 / 0.791 -> en:bcma-specific car-expressing t lymphocytes
    n1=en:beractant | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=34
  11. en:beractant -- r_associated #0: 34 / 0.791 -> en:cd138car-cd137/tcrzeta-expressing t lymphocytes
    n1=en:beractant | n2=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | rel=r_associated | relid=0 | w=34
  12. en:beractant -- r_associated #0: 34 / 0.791 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=en:beractant | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=34
  13. en:beractant -- r_associated #0: 34 / 0.791 -> en:plant nectar
    n1=en:beractant | n2=en:plant nectar | rel=r_associated | relid=0 | w=34
  14. en:beractant -- r_associated #0: 34 / 0.791 -> en:recombinant growth factor
    n1=en:beractant | n2=en:recombinant growth factor | rel=r_associated | relid=0 | w=34
  15. en:beractant -- r_associated #0: 32 / 0.744 -> en:anti-prolactin receptor antibody lfa102
    n1=en:beractant | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=32
  16. en:beractant -- r_associated #0: 32 / 0.744 -> en:autologous mesenchymal stem cells apceth_101
    n1=en:beractant | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=32
  17. en:beractant -- r_associated #0: 32 / 0.744 -> en:cord blood-derived expanded natural killer cells pnk-007
    n1=en:beractant | n2=en:cord blood-derived expanded natural killer cells pnk-007 | rel=r_associated | relid=0 | w=32
  18. en:beractant -- r_associated #0: 32 / 0.744 -> en:genetically engineered hematopoietic stem progenitor cells
    n1=en:beractant | n2=en:genetically engineered hematopoietic stem progenitor cells | rel=r_associated | relid=0 | w=32
  19. en:beractant -- r_associated #0: 32 / 0.744 -> en:human placenta hydrolysate
    n1=en:beractant | n2=en:human placenta hydrolysate | rel=r_associated | relid=0 | w=32
  20. en:beractant -- r_associated #0: 32 / 0.744 -> en:lenti-d/abcd1-transduced autologous hematopoietic stem cells
    n1=en:beractant | n2=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | rel=r_associated | relid=0 | w=32
  21. en:beractant -- r_associated #0: 32 / 0.744 -> en:omonasteine
    n1=en:beractant | n2=en:omonasteine | rel=r_associated | relid=0 | w=32
  22. en:beractant -- r_associated #0: 32 / 0.744 -> en:oxabrexine
    n1=en:beractant | n2=en:oxabrexine | rel=r_associated | relid=0 | w=32
  23. en:beractant -- r_associated #0: 32 / 0.744 -> en:recombinant cell-surface anchored sialidase das181
    n1=en:beractant | n2=en:recombinant cell-surface anchored sialidase das181 | rel=r_associated | relid=0 | w=32
  24. en:beractant -- r_associated #0: 32 / 0.744 -> en:telmesteine
    n1=en:beractant | n2=en:telmesteine | rel=r_associated | relid=0 | w=32
  25. en:beractant -- r_associated #0: 31 / 0.721 -> en:acellular cadaveric dermal matrix
    n1=en:beractant | n2=en:acellular cadaveric dermal matrix | rel=r_associated | relid=0 | w=31
  26. en:beractant -- r_associated #0: 31 / 0.721 -> en:adamexine
    n1=en:beractant | n2=en:adamexine | rel=r_associated | relid=0 | w=31
  27. en:beractant -- r_associated #0: 31 / 0.721 -> en:cells [chemical/ingredient]
    n1=en:beractant | n2=en:cells [chemical/ingredient] | rel=r_associated | relid=0 | w=31
  28. en:beractant -- r_associated #0: 31 / 0.721 -> en:erdosteine
    n1=en:beractant | n2=en:erdosteine | rel=r_associated | relid=0 | w=31
  29. en:beractant -- r_associated #0: 31 / 0.721 -> en:neltenexine
    n1=en:beractant | n2=en:neltenexine | rel=r_associated | relid=0 | w=31
  30. en:beractant -- r_associated #0: 31 / 0.721 -> en:therapeutic angiotensin-(1-7)
    n1=en:beractant | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=31
  31. en:beractant -- r_associated #0: 30 / 0.698 -> en:anti-asthmatic agent
    n1=en:beractant | n2=en:anti-asthmatic agent | rel=r_associated | relid=0 | w=30
  32. en:beractant -- r_associated #0: 30 / 0.698 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=en:beractant | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=30
  33. en:beractant -- r_associated #0: 30 / 0.698 -> en:artificial lung expanding compound
    n1=en:beractant | n2=en:artificial lung expanding compound | rel=r_associated | relid=0 | w=30
  34. en:beractant -- r_associated #0: 30 / 0.698 -> en:cartasteine
    n1=en:beractant | n2=en:cartasteine | rel=r_associated | relid=0 | w=30
  35. en:beractant -- r_associated #0: 30 / 0.698 -> en:cistinexine
    n1=en:beractant | n2=en:cistinexine | rel=r_associated | relid=0 | w=30
  36. en:beractant -- r_associated #0: 30 / 0.698 -> en:donor regulatory t-lymphocytes
    n1=en:beractant | n2=en:donor regulatory t-lymphocytes | rel=r_associated | relid=0 | w=30
  37. en:beractant -- r_associated #0: 30 / 0.698 -> en:enzyme replacement or supplement agent
    n1=en:beractant | n2=en:enzyme replacement or supplement agent | rel=r_associated | relid=0 | w=30
  38. en:beractant -- r_associated #0: 30 / 0.698 -> en:oncolytic virus
    n1=en:beractant | n2=en:oncolytic virus | rel=r_associated | relid=0 | w=30
  39. en:beractant -- r_associated #0: 30 / 0.698 -> en:transduction gene
    n1=en:beractant | n2=en:transduction gene | rel=r_associated | relid=0 | w=30
  40. en:beractant -- r_associated #0: 30 / 0.698 -> surfactant ta
    n1=en:beractant | n2=surfactant ta | rel=r_associated | relid=0 | w=30
  41. en:beractant -- r_associated #0: 29 / 0.674 -> en:antitussive agent
    n1=en:beractant | n2=en:antitussive agent | rel=r_associated | relid=0 | w=29
  42. en:beractant -- r_associated #0: 29 / 0.674 -> en:beractant intratracheal suspension [survanta]
    n1=en:beractant | n2=en:beractant intratracheal suspension [survanta] | rel=r_associated | relid=0 | w=29
  43. en:beractant -- r_associated #0: 29 / 0.674 -> en:bone meal
    n1=en:beractant | n2=en:bone meal | rel=r_associated | relid=0 | w=29
  44. en:beractant -- r_associated #0: 29 / 0.674 -> en:calfactant
    n1=en:beractant | n2=en:calfactant | rel=r_associated | relid=0 | w=29
  45. en:beractant -- r_associated #0: 29 / 0.674 -> en:dual variable domain immunoglobulin abt-165
    n1=en:beractant | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=29
  46. en:beractant -- r_associated #0: 29 / 0.674 -> en:expanded umbilical cord blood product hsc835
    n1=en:beractant | n2=en:expanded umbilical cord blood product hsc835 | rel=r_associated | relid=0 | w=29
  47. en:beractant -- r_associated #0: 29 / 0.674 -> en:fap-specific cd8-positive t cells
    n1=en:beractant | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=29
  48. en:beractant -- r_associated #0: 29 / 0.674 -> en:gene transfer or gene delivery agent
    n1=en:beractant | n2=en:gene transfer or gene delivery agent | rel=r_associated | relid=0 | w=29
  49. en:beractant -- r_associated #0: 29 / 0.674 -> en:hsp70-peptide tkd/il-2-activated autologous natural killer cells
    n1=en:beractant | n2=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | rel=r_associated | relid=0 | w=29
  50. en:beractant -- r_associated #0: 29 / 0.674 -> en:human immunoglobulin g
    n1=en:beractant | n2=en:human immunoglobulin g | rel=r_associated | relid=0 | w=29
  51. en:beractant -- r_associated #0: 29 / 0.674 -> en:picibanil
    n1=en:beractant | n2=en:picibanil | rel=r_associated | relid=0 | w=29
  52. en:beractant -- r_associated #0: 29 / 0.674 -> en:protein
    n1=en:beractant | n2=en:protein | rel=r_associated | relid=0 | w=29
  53. en:beractant -- r_associated #0: 29 / 0.674 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=en:beractant | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=29
  54. en:beractant -- r_associated #0: 28 / 0.651 -> en:acetylcysteine 200 mg/ml inhalant solution
    n1=en:beractant | n2=en:acetylcysteine 200 mg/ml inhalant solution | rel=r_associated | relid=0 | w=28
  55. en:beractant -- r_associated #0: 28 / 0.651 -> en:beractant intratracheal suspension
    n1=en:beractant | n2=en:beractant intratracheal suspension | rel=r_associated | relid=0 | w=28
  56. en:beractant -- r_associated #0: 28 / 0.651 -> en:biosimilar pharmaceuticals
    n1=en:beractant | n2=en:biosimilar pharmaceuticals | rel=r_associated | relid=0 | w=28
  57. en:beractant -- r_associated #0: 28 / 0.651 -> en:bovine pituitary extract
    n1=en:beractant | n2=en:bovine pituitary extract | rel=r_associated | relid=0 | w=28
  58. en:beractant -- r_associated #0: 28 / 0.651 -> en:brovanexine hydrochloride
    n1=en:beractant | n2=en:brovanexine hydrochloride | rel=r_associated | relid=0 | w=28
  59. en:beractant -- r_associated #0: 28 / 0.651 -> en:dembrexine
    n1=en:beractant | n2=en:dembrexine | rel=r_associated | relid=0 | w=28
  60. en:beractant -- r_associated #0: 28 / 0.651 -> en:lymphoma taa-specific cytotoxic t lymphocytes
    n1=en:beractant | n2=en:lymphoma taa-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=28
  61. en:beractant -- r_associated #0: 28 / 0.651 -> en:monoclonal antibody
    n1=en:beractant | n2=en:monoclonal antibody | rel=r_associated | relid=0 | w=28
  62. en:beractant -- r_associated #0: 28 / 0.651 -> en:ny-eso-1-specific cd4-positive t lymphocytes
    n1=en:beractant | n2=en:ny-eso-1-specific cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=28
  63. en:beractant -- r_associated #0: 28 / 0.651 -> en:prenisteine
    n1=en:beractant | n2=en:prenisteine | rel=r_associated | relid=0 | w=28
  64. en:beractant -- r_associated #0: 28 / 0.651 -> en:stepronin
    n1=en:beractant | n2=en:stepronin | rel=r_associated | relid=0 | w=28
  65. en:beractant -- r_associated #0: 28 / 0.651 -> extrait d'un surfactant de poumon de veau modifié
    n1=en:beractant | n2=extrait d'un surfactant de poumon de veau modifié | rel=r_associated | relid=0 | w=28
  66. en:beractant -- r_associated #0: 27 / 0.628 -> en:alonacic
    n1=en:beractant | n2=en:alonacic | rel=r_associated | relid=0 | w=27
  67. en:beractant -- r_associated #0: 27 / 0.628 -> en:biological agent
    n1=en:beractant | n2=en:biological agent | rel=r_associated | relid=0 | w=27
  68. en:beractant -- r_associated #0: 27 / 0.628 -> en:danosteine
    n1=en:beractant | n2=en:danosteine | rel=r_associated | relid=0 | w=27
  69. en:beractant -- r_associated #0: 27 / 0.628 -> en:gene therapy agent
    n1=en:beractant | n2=en:gene therapy agent | rel=r_associated | relid=0 | w=27
  70. en:beractant -- r_associated #0: 27 / 0.628 -> en:her2-targeting antibody fc fragment fs102
    n1=en:beractant | n2=en:her2-targeting antibody fc fragment fs102 | rel=r_associated | relid=0 | w=27
  71. en:beractant -- r_associated #0: 27 / 0.628 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=en:beractant | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=27
  72. en:beractant -- r_associated #0: 27 / 0.628 -> en:ularitide
    n1=en:beractant | n2=en:ularitide | rel=r_associated | relid=0 | w=27
  73. en:beractant -- r_associated #0: 27 / 0.628 -> extrait de poumon de bovin
    n1=en:beractant | n2=extrait de poumon de bovin | rel=r_associated | relid=0 | w=27
  74. en:beractant -- r_associated #0: 27 / 0.628 -> protéine
    n1=en:beractant | n2=protéine | rel=r_associated | relid=0 | w=27
  75. en:beractant -- r_associated #0: 26 / 0.605 -> en:ambroxol
    n1=en:beractant | n2=en:ambroxol | rel=r_associated | relid=0 | w=26
  76. en:beractant -- r_associated #0: 26 / 0.605 -> en:antisense oligonucleotides
    n1=en:beractant | n2=en:antisense oligonucleotides | rel=r_associated | relid=0 | w=26
  77. en:beractant -- r_associated #0: 26 / 0.605 -> en:denufosol
    n1=en:beractant | n2=en:denufosol | rel=r_associated | relid=0 | w=26
  78. en:beractant -- r_associated #0: 26 / 0.605 -> en:hydrochloride, bromhexine
    n1=en:beractant | n2=en:hydrochloride, bromhexine | rel=r_associated | relid=0 | w=26
  79. en:beractant -- r_associated #0: 26 / 0.605 -> en:interferon beta-secreting mesenchymal stem cells
    n1=en:beractant | n2=en:interferon beta-secreting mesenchymal stem cells | rel=r_associated | relid=0 | w=26
  80. en:beractant -- r_associated #0: 26 / 0.605 -> en:poractant alfa
    n1=en:beractant | n2=en:poractant alfa | rel=r_associated | relid=0 | w=26
  81. en:beractant -- r_associated #0: 26 / 0.605 -> en:serum-derived bovine immunoglobulin protein isolate
    n1=en:beractant | n2=en:serum-derived bovine immunoglobulin protein isolate | rel=r_associated | relid=0 | w=26
  82. en:beractant -- r_associated #0: 26 / 0.605 -> en:surfactant activity [moa]
    n1=en:beractant | n2=en:surfactant activity [moa] | rel=r_associated | relid=0 | w=26
  83. en:beractant -- r_associated #0: 26 / 0.605 -> en:thrombopoietin receptor agonist lgd-4665
    n1=en:beractant | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=26
  84. en:beractant -- r_associated #0: 25 / 0.581 -> béractant
    n1=en:beractant | n2=béractant | rel=r_associated | relid=0 | w=25
  85. en:beractant -- r_associated #0: 25 / 0.581 -> en:acetylcysteine 100 mg/ml inhalant solution
    n1=en:beractant | n2=en:acetylcysteine 100 mg/ml inhalant solution | rel=r_associated | relid=0 | w=25
  86. en:beractant -- r_associated #0: 25 / 0.581 -> en:adipose-derived stromal vascular fraction cells
    n1=en:beractant | n2=en:adipose-derived stromal vascular fraction cells | rel=r_associated | relid=0 | w=25
  87. en:beractant -- r_associated #0: 25 / 0.581 -> en:algal product
    n1=en:beractant | n2=en:algal product | rel=r_associated | relid=0 | w=25
  88. en:beractant -- r_associated #0: 25 / 0.581 -> en:ambroxol hydrochloride
    n1=en:beractant | n2=en:ambroxol hydrochloride | rel=r_associated | relid=0 | w=25
  89. en:beractant -- r_associated #0: 25 / 0.581 -> en:antiserum
    n1=en:beractant | n2=en:antiserum | rel=r_associated | relid=0 | w=25
  90. en:beractant -- r_associated #0: 25 / 0.581 -> en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=en:beractant | n2=en:autologous anti-hpv-16 e6 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=25
  91. en:beractant -- r_associated #0: 25 / 0.581 -> en:autologous chondrocyte cell preparation
    n1=en:beractant | n2=en:autologous chondrocyte cell preparation | rel=r_associated | relid=0 | w=25
  92. en:beractant -- r_associated #0: 25 / 0.581 -> en:bencisteine
    n1=en:beractant | n2=en:bencisteine | rel=r_associated | relid=0 | w=25
  93. en:beractant -- r_associated #0: 25 / 0.581 -> en:beractant 200mg/8ml suspension
    n1=en:beractant | n2=en:beractant 200mg/8ml suspension | rel=r_associated | relid=0 | w=25
  94. en:beractant -- r_associated #0: 25 / 0.581 -> en:blood group antigen precursor
    n1=en:beractant | n2=en:blood group antigen precursor | rel=r_associated | relid=0 | w=25
  95. en:beractant -- r_associated #0: 25 / 0.581 -> en:blood material
    n1=en:beractant | n2=en:blood material | rel=r_associated | relid=0 | w=25
  96. en:beractant -- r_associated #0: 25 / 0.581 -> en:blood product
    n1=en:beractant | n2=en:blood product | rel=r_associated | relid=0 | w=25
  97. en:beractant -- r_associated #0: 25 / 0.581 -> en:botulinum toxins
    n1=en:beractant | n2=en:botulinum toxins | rel=r_associated | relid=0 | w=25
  98. en:beractant -- r_associated #0: 25 / 0.581 -> en:bromhexine
    n1=en:beractant | n2=en:bromhexine | rel=r_associated | relid=0 | w=25
  99. en:beractant -- r_associated #0: 25 / 0.581 -> en:carbocysteine
    n1=en:beractant | n2=en:carbocysteine | rel=r_associated | relid=0 | w=25
  100. en:beractant -- r_associated #0: 25 / 0.581 -> en:cd28car/cd137car-expressing t-lymphocytes
    n1=en:beractant | n2=en:cd28car/cd137car-expressing t-lymphocytes | rel=r_associated | relid=0 | w=25
  101. en:beractant -- r_associated #0: 25 / 0.581 -> en:chemotactic factor inactivator
    n1=en:beractant | n2=en:chemotactic factor inactivator | rel=r_associated | relid=0 | w=25
  102. en:beractant -- r_associated #0: 25 / 0.581 -> en:collagen
    n1=en:beractant | n2=en:collagen | rel=r_associated | relid=0 | w=25
  103. en:beractant -- r_associated #0: 25 / 0.581 -> en:collagen + procollagen
    n1=en:beractant | n2=en:collagen + procollagen | rel=r_associated | relid=0 | w=25
  104. en:beractant -- r_associated #0: 25 / 0.581 -> en:dacisteine
    n1=en:beractant | n2=en:dacisteine | rel=r_associated | relid=0 | w=25
  105. en:beractant -- r_associated #0: 25 / 0.581 -> en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes
    n1=en:beractant | n2=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | rel=r_associated | relid=0 | w=25
  106. en:beractant -- r_associated #0: 25 / 0.581 -> en:escherichia coli antibody
    n1=en:beractant | n2=en:escherichia coli antibody | rel=r_associated | relid=0 | w=25
  107. en:beractant -- r_associated #0: 25 / 0.581 -> en:eucalyptol
    n1=en:beractant | n2=en:eucalyptol | rel=r_associated | relid=0 | w=25
  108. en:beractant -- r_associated #0: 25 / 0.581 -> en:expectorant
    n1=en:beractant | n2=en:expectorant | rel=r_associated | relid=0 | w=25
  109. en:beractant -- r_associated #0: 25 / 0.581 -> en:gelatin
    n1=en:beractant | n2=en:gelatin | rel=r_associated | relid=0 | w=25
  110. en:beractant -- r_associated #0: 25 / 0.581 -> en:gene transduction agent
    n1=en:beractant | n2=en:gene transduction agent | rel=r_associated | relid=0 | w=25
  111. en:beractant -- r_associated #0: 25 / 0.581 -> en:gene-modified hiv-protected hematopoietic stem cells
    n1=en:beractant | n2=en:gene-modified hiv-protected hematopoietic stem cells | rel=r_associated | relid=0 | w=25
  112. en:beractant -- r_associated #0: 25 / 0.581 -> en:genetically engineered ny-eso-1-specific t lymphocytes
    n1=en:beractant | n2=en:genetically engineered ny-eso-1-specific t lymphocytes | rel=r_associated | relid=0 | w=25
  113. en:beractant -- r_associated #0: 25 / 0.581 -> en:growth substances
    n1=en:beractant | n2=en:growth substances | rel=r_associated | relid=0 | w=25
  114. en:beractant -- r_associated #0: 25 / 0.581 -> en:guaisteine
    n1=en:beractant | n2=en:guaisteine | rel=r_associated | relid=0 | w=25
  115. en:beractant -- r_associated #0: 25 / 0.581 -> en:hematopoietic factor
    n1=en:beractant | n2=en:hematopoietic factor | rel=r_associated | relid=0 | w=25
  116. en:beractant -- r_associated #0: 25 / 0.581 -> en:hemostasis related substance
    n1=en:beractant | n2=en:hemostasis related substance | rel=r_associated | relid=0 | w=25
  117. en:beractant -- r_associated #0: 25 / 0.581 -> en:heterodimeric interleukin-15
    n1=en:beractant | n2=en:heterodimeric interleukin-15 | rel=r_associated | relid=0 | w=25
  118. en:beractant -- r_associated #0: 25 / 0.581 -> en:human immunoglobulin m
    n1=en:beractant | n2=en:human immunoglobulin m | rel=r_associated | relid=0 | w=25
  119. en:beractant -- r_associated #0: 25 / 0.581 -> en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells
    n1=en:beractant | n2=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | rel=r_associated | relid=0 | w=25
  120. en:beractant -- r_associated #0: 25 / 0.581 -> en:immunologic factors
    n1=en:beractant | n2=en:immunologic factors | rel=r_associated | relid=0 | w=25
  121. en:beractant -- r_associated #0: 25 / 0.581 -> en:inducible cd4+cd25+ regulatory t cells
    n1=en:beractant | n2=en:inducible cd4+cd25+ regulatory t cells | rel=r_associated | relid=0 | w=25
  122. en:beractant -- r_associated #0: 25 / 0.581 -> en:interleukin-11
    n1=en:beractant | n2=en:interleukin-11 | rel=r_associated | relid=0 | w=25
  123. en:beractant -- r_associated #0: 25 / 0.581 -> en:isalsteine
    n1=en:beractant | n2=en:isalsteine | rel=r_associated | relid=0 | w=25
  124. en:beractant -- r_associated #0: 25 / 0.581 -> en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells
    n1=en:beractant | n2=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=25
  125. en:beractant -- r_associated #0: 25 / 0.581 -> en:lucinactant
    n1=en:beractant | n2=en:lucinactant | rel=r_associated | relid=0 | w=25
  126. en:beractant -- r_associated #0: 25 / 0.581 -> en:lusupultide
    n1=en:beractant | n2=en:lusupultide | rel=r_associated | relid=0 | w=25
  127. en:beractant -- r_associated #0: 25 / 0.581 -> en:mecysteine hydrochloride
    n1=en:beractant | n2=en:mecysteine hydrochloride | rel=r_associated | relid=0 | w=25
  128. en:beractant -- r_associated #0: 25 / 0.581 -> en:microbial agent
    n1=en:beractant | n2=en:microbial agent | rel=r_associated | relid=0 | w=25
  129. en:beractant -- r_associated #0: 25 / 0.581 -> en:nervous system hormone-like substance
    n1=en:beractant | n2=en:nervous system hormone-like substance | rel=r_associated | relid=0 | w=25
  130. en:beractant -- r_associated #0: 25 / 0.581 -> en:nutrient
    n1=en:beractant | n2=en:nutrient | rel=r_associated | relid=0 | w=25
  131. en:beractant -- r_associated #0: 25 / 0.581 -> en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301
    n1=en:beractant | n2=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | rel=r_associated | relid=0 | w=25
  132. en:beractant -- r_associated #0: 25 / 0.581 -> en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells
    n1=en:beractant | n2=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | rel=r_associated | relid=0 | w=25
  133. en:beractant -- r_associated #0: 25 / 0.581 -> en:organic natural material
    n1=en:beractant | n2=en:organic natural material | rel=r_associated | relid=0 | w=25
  134. en:beractant -- r_associated #0: 25 / 0.581 -> en:plant exudates
    n1=en:beractant | n2=en:plant exudates | rel=r_associated | relid=0 | w=25
  135. en:beractant -- r_associated #0: 25 / 0.581 -> en:plant preparations
    n1=en:beractant | n2=en:plant preparations | rel=r_associated | relid=0 | w=25
  136. en:beractant -- r_associated #0: 25 / 0.581 -> en:pronase oral solution
    n1=en:beractant | n2=en:pronase oral solution | rel=r_associated | relid=0 | w=25
  137. en:beractant -- r_associated #0: 25 / 0.581 -> en:protein-bound iodine
    n1=en:beractant | n2=en:protein-bound iodine | rel=r_associated | relid=0 | w=25
  138. en:beractant -- r_associated #0: 25 / 0.581 -> en:receptor
    n1=en:beractant | n2=en:receptor | rel=r_associated | relid=0 | w=25
  139. en:beractant -- r_associated #0: 25 / 0.581 -> en:recombinant human apolipoprotein(a) kringle v mg1102
    n1=en:beractant | n2=en:recombinant human apolipoprotein(a) kringle v mg1102 | rel=r_associated | relid=0 | w=25
  140. en:beractant -- r_associated #0: 25 / 0.581 -> en:saccharomyces cerevisiae rna
    n1=en:beractant | n2=en:saccharomyces cerevisiae rna | rel=r_associated | relid=0 | w=25
  141. en:beractant -- r_associated #0: 25 / 0.581 -> en:sirna-transfected peripheral blood mononuclear cells apn401
    n1=en:beractant | n2=en:sirna-transfected peripheral blood mononuclear cells apn401 | rel=r_associated | relid=0 | w=25
  142. en:beractant -- r_associated #0: 25 / 0.581 -> en:sobrerol
    n1=en:beractant | n2=en:sobrerol | rel=r_associated | relid=0 | w=25
  143. en:beractant -- r_associated #0: 25 / 0.581 -> en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
    n1=en:beractant | n2=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | rel=r_associated | relid=0 | w=25
  144. en:beractant -- r_associated #0: 25 / 0.581 -> en:surfactant [epc]
    n1=en:beractant | n2=en:surfactant [epc] | rel=r_associated | relid=0 | w=25
  145. en:beractant -- r_associated #0: 25 / 0.581 -> en:survanta intratracheal
    n1=en:beractant | n2=en:survanta intratracheal | rel=r_associated | relid=0 | w=25
  146. en:beractant -- r_associated #0: 25 / 0.581 -> en:synthetic copolymer
    n1=en:beractant | n2=en:synthetic copolymer | rel=r_associated | relid=0 | w=25
  147. en:beractant -- r_associated #0: 25 / 0.581 -> en:taurosteine
    n1=en:beractant | n2=en:taurosteine | rel=r_associated | relid=0 | w=25
  148. en:beractant -- r_associated #0: 25 / 0.581 -> en:therapeutic allogeneic lymphocytes
    n1=en:beractant | n2=en:therapeutic allogeneic lymphocytes | rel=r_associated | relid=0 | w=25
  149. en:beractant -- r_associated #0: 25 / 0.581 -> en:topical wound spray hp802-247
    n1=en:beractant | n2=en:topical wound spray hp802-247 | rel=r_associated | relid=0 | w=25
  150. en:beractant -- r_associated #0: 25 / 0.581 -> en:toxoids
    n1=en:beractant | n2=en:toxoids | rel=r_associated | relid=0 | w=25
  151. en:beractant -- r_associated #0: 25 / 0.581 -> en:tumor-cells apoptosis factor hormone-peptide
    n1=en:beractant | n2=en:tumor-cells apoptosis factor hormone-peptide | rel=r_associated | relid=0 | w=25
  152. en:beractant -- r_associated #0: 25 / 0.581 -> en:tyloxapol
    n1=en:beractant | n2=en:tyloxapol | rel=r_associated | relid=0 | w=25
  153. en:beractant -- r_associated #0: 25 / 0.581 -> en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells
    n1=en:beractant | n2=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | rel=r_associated | relid=0 | w=25
  154. en:beractant -- r_associated #0: 25 / 0.581 -> en:vaccine, immunoglobulins and antisera
    n1=en:beractant | n2=en:vaccine, immunoglobulins and antisera | rel=r_associated | relid=0 | w=25
  155. en:beractant -- r_associated #0: 25 / 0.581 -> en:viruses ingredient
    n1=en:beractant | n2=en:viruses ingredient | rel=r_associated | relid=0 | w=25
  156. en:beractant -- r_associated #0: 25 / 0.581 -> surfactant tokyo-akita
    n1=en:beractant | n2=surfactant tokyo-akita | rel=r_associated | relid=0 | w=25
  157. en:beractant -- r_associated #0: 24 / 0.558 -> en:survanta intratracheal product
    n1=en:beractant | n2=en:survanta intratracheal product | rel=r_associated | relid=0 | w=24
  158. en:beractant -- r_associated #0: 23 / 0.535 -> en:alveolar surface tension reduction [pe]
    n1=en:beractant | n2=en:alveolar surface tension reduction [pe] | rel=r_associated | relid=0 | w=23
  159. en:beractant -- r_associated #0: 21 / 0.488 -> en:4scar-gd2-modified t-lymphocytes
    n1=en:beractant | n2=en:4scar-gd2-modified t-lymphocytes | rel=r_associated | relid=0 | w=21
  160. en:beractant -- r_associated #0: 20 / 0.465 -> acétylcystéine
    n1=en:beractant | n2=acétylcystéine | rel=r_associated | relid=0 | w=20
  161. en:beractant -- r_associated #0: 20 / 0.465 -> agent biologique
    n1=en:beractant | n2=agent biologique | rel=r_associated | relid=0 | w=20
  162. en:beractant -- r_associated #0: 20 / 0.465 -> agent mucolytique
    n1=en:beractant | n2=agent mucolytique | rel=r_associated | relid=0 | w=20
  163. en:beractant -- r_associated #0: 20 / 0.465 -> allergie à un médicament
    n1=en:beractant | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  164. en:beractant -- r_associated #0: 20 / 0.465 -> allergie aux médicaments
    n1=en:beractant | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  165. en:beractant -- r_associated #0: 20 / 0.465 -> allergie médicamenteuse
    n1=en:beractant | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  166. en:beractant -- r_associated #0: 20 / 0.465 -> ambroxol
    n1=en:beractant | n2=ambroxol | rel=r_associated | relid=0 | w=20
  167. en:beractant -- r_associated #0: 20 / 0.465 -> anticorps monoclonal
    n1=en:beractant | n2=anticorps monoclonal | rel=r_associated | relid=0 | w=20
  168. en:beractant -- r_associated #0: 20 / 0.465 -> Anticorps monoclonal
    n1=en:beractant | n2=Anticorps monoclonal | rel=r_associated | relid=0 | w=20
  169. en:beractant -- r_associated #0: 20 / 0.465 -> antigène
    n1=en:beractant | n2=antigène | rel=r_associated | relid=0 | w=20
  170. en:beractant -- r_associated #0: 20 / 0.465 -> cow-pox
    n1=en:beractant | n2=cow-pox | rel=r_associated | relid=0 | w=20
  171. en:beractant -- r_associated #0: 20 / 0.465 -> cowpox
    n1=en:beractant | n2=cowpox | rel=r_associated | relid=0 | w=20
  172. en:beractant -- r_associated #0: 20 / 0.465 -> en:3d-expanded placenta-derived cells plx-r18
    n1=en:beractant | n2=en:3d-expanded placenta-derived cells plx-r18 | rel=r_associated | relid=0 | w=20
  173. en:beractant -- r_associated #0: 20 / 0.465 -> en:adoptive cell therapy agent
    n1=en:beractant | n2=en:adoptive cell therapy agent | rel=r_associated | relid=0 | w=20
  174. en:beractant -- r_associated #0: 20 / 0.465 -> en:alpha-1-proteinase inhibitor human
    n1=en:beractant | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=20
  175. en:beractant -- r_associated #0: 20 / 0.465 -> en:anthrax vaccine adsorbed
    n1=en:beractant | n2=en:anthrax vaccine adsorbed | rel=r_associated | relid=0 | w=20
  176. en:beractant -- r_associated #0: 20 / 0.465 -> en:anti-cd22 car-expressing t lymphocytes
    n1=en:beractant | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  177. en:beractant -- r_associated #0: 20 / 0.465 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=en:beractant | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=20
  178. en:beractant -- r_associated #0: 20 / 0.465 -> en:anti-tumor necrosis factor alpha drug
    n1=en:beractant | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=20
  179. en:beractant -- r_associated #0: 20 / 0.465 -> en:antigen
    n1=en:beractant | n2=en:antigen | rel=r_associated | relid=0 | w=20
  180. en:beractant -- r_associated #0: 20 / 0.465 -> en:autologous interferon-producing killer dendritic cells
    n1=en:beractant | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=20
  181. en:beractant -- r_associated #0: 20 / 0.465 -> en:autologous pbmcs in gm-csf
    n1=en:beractant | n2=en:autologous pbmcs in gm-csf | rel=r_associated | relid=0 | w=20
  182. en:beractant -- r_associated #0: 20 / 0.465 -> en:belladonna alkaloid- and butabarbital-containing product
    n1=en:beractant | n2=en:belladonna alkaloid- and butabarbital-containing product | rel=r_associated | relid=0 | w=20
  183. en:beractant -- r_associated #0: 20 / 0.465 -> en:blood derivative product
    n1=en:beractant | n2=en:blood derivative product | rel=r_associated | relid=0 | w=20
  184. en:beractant -- r_associated #0: 20 / 0.465 -> en:blood group antigen carrier
    n1=en:beractant | n2=en:blood group antigen carrier | rel=r_associated | relid=0 | w=20
  185. en:beractant -- r_associated #0: 20 / 0.465 -> en:bluefish allergenic extract
    n1=en:beractant | n2=en:bluefish allergenic extract | rel=r_associated | relid=0 | w=20
  186. en:beractant -- r_associated #0: 20 / 0.465 -> en:bos taurus hip joint preparation
    n1=en:beractant | n2=en:bos taurus hip joint preparation | rel=r_associated | relid=0 | w=20
  187. en:beractant -- r_associated #0: 20 / 0.465 -> en:brimonidine + timolol
    n1=en:beractant | n2=en:brimonidine + timolol | rel=r_associated | relid=0 | w=20
  188. en:beractant -- r_associated #0: 20 / 0.465 -> en:bromodiphenhydramine+codeine
    n1=en:beractant | n2=en:bromodiphenhydramine+codeine | rel=r_associated | relid=0 | w=20
  189. en:beractant -- r_associated #0: 20 / 0.465 -> en:brompheniramine + pseudoephedrine
    n1=en:beractant | n2=en:brompheniramine + pseudoephedrine | rel=r_associated | relid=0 | w=20
  190. en:beractant -- r_associated #0: 20 / 0.465 -> en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride
    n1=en:beractant | n2=en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride | rel=r_associated | relid=0 | w=20
  191. en:beractant -- r_associated #0: 20 / 0.465 -> en:brovanexine
    n1=en:beractant | n2=en:brovanexine | rel=r_associated | relid=0 | w=20
  192. en:beractant -- r_associated #0: 20 / 0.465 -> en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs
    n1=en:beractant | n2=en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs | rel=r_associated | relid=0 | w=20
  193. en:beractant -- r_associated #0: 20 / 0.465 -> en:cathelicidin ll-37
    n1=en:beractant | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=20
  194. en:beractant -- r_associated #0: 20 / 0.465 -> en:colfosceril
    n1=en:beractant | n2=en:colfosceril | rel=r_associated | relid=0 | w=20
  195. en:beractant -- r_associated #0: 20 / 0.465 -> en:colfosceril palmitate
    n1=en:beractant | n2=en:colfosceril palmitate | rel=r_associated | relid=0 | w=20
  196. en:beractant -- r_associated #0: 20 / 0.465 -> en:colony stimulating factor
    n1=en:beractant | n2=en:colony stimulating factor | rel=r_associated | relid=0 | w=20
  197. en:beractant -- r_associated #0: 20 / 0.465 -> en:cowpox
    n1=en:beractant | n2=en:cowpox | rel=r_associated | relid=0 | w=20
  198. en:beractant -- r_associated #0: 20 / 0.465 -> en:danthron and poloxamer 188 product
    n1=en:beractant | n2=en:danthron and poloxamer 188 product | rel=r_associated | relid=0 | w=20
  199. en:beractant -- r_associated #0: 20 / 0.465 -> en:dehydrated human amnion/chorion membrane
    n1=en:beractant | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=20
  200. en:beractant -- r_associated #0: 20 / 0.465 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=en:beractant | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=20
  201. en:beractant -- r_associated #0: 20 / 0.465 -> en:denileukin diftitox
    n1=en:beractant | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=20
  202. en:beractant -- r_associated #0: 20 / 0.465 -> en:domiodol
    n1=en:beractant | n2=en:domiodol | rel=r_associated | relid=0 | w=20
  203. en:beractant -- r_associated #0: 20 / 0.465 -> en:dornase alfa
    n1=en:beractant | n2=en:dornase alfa | rel=r_associated | relid=0 | w=20
  204. en:beractant -- r_associated #0: 20 / 0.465 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=en:beractant | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=20
  205. en:beractant -- r_associated #0: 20 / 0.465 -> en:drug allergy
    n1=en:beractant | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
  206. en:beractant -- r_associated #0: 20 / 0.465 -> en:eprazinone
    n1=en:beractant | n2=en:eprazinone | rel=r_associated | relid=0 | w=20
  207. en:beractant -- r_associated #0: 20 / 0.465 -> en:fda established names and unique ingredient identifier codes terminology
    n1=en:beractant | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
  208. en:beractant -- r_associated #0: 20 / 0.465 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=en:beractant | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=20
  209. en:beractant -- r_associated #0: 20 / 0.465 -> en:gene
    n1=en:beractant | n2=en:gene | rel=r_associated | relid=0 | w=20
  210. en:beractant -- r_associated #0: 20 / 0.465 -> en:green soap
    n1=en:beractant | n2=en:green soap | rel=r_associated | relid=0 | w=20
  211. en:beractant -- r_associated #0: 20 / 0.465 -> en:human immunoglobulin a
    n1=en:beractant | n2=en:human immunoglobulin a | rel=r_associated | relid=0 | w=20
  212. en:beractant -- r_associated #0: 20 / 0.465 -> en:human menopausal gonadotrophin
    n1=en:beractant | n2=en:human menopausal gonadotrophin | rel=r_associated | relid=0 | w=20
  213. en:beractant -- r_associated #0: 20 / 0.465 -> en:human menopausal gonadotropin
    n1=en:beractant | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=20
  214. en:beractant -- r_associated #0: 20 / 0.465 -> en:interleukin-2
    n1=en:beractant | n2=en:interleukin-2 | rel=r_associated | relid=0 | w=20
  215. en:beractant -- r_associated #0: 20 / 0.465 -> en:letosteine
    n1=en:beractant | n2=en:letosteine | rel=r_associated | relid=0 | w=20
  216. en:beractant -- r_associated #0: 20 / 0.465 -> en:live yeast cell derivative
    n1=en:beractant | n2=en:live yeast cell derivative | rel=r_associated | relid=0 | w=20
  217. en:beractant -- r_associated #0: 20 / 0.465 -> en:meat and bone flour
    n1=en:beractant | n2=en:meat and bone flour | rel=r_associated | relid=0 | w=20
  218. en:beractant -- r_associated #0: 20 / 0.465 -> en:mecysteine
    n1=en:beractant | n2=en:mecysteine | rel=r_associated | relid=0 | w=20
  219. en:beractant -- r_associated #0: 20 / 0.465 -> en:medicinal allergy
    n1=en:beractant | n2=en:medicinal allergy | rel=r_associated | relid=0 | w=20
  220. en:beractant -- r_associated #0: 20 / 0.465 -> en:mirasol-treated allogeneic platelets
    n1=en:beractant | n2=en:mirasol-treated allogeneic platelets | rel=r_associated | relid=0 | w=20
  221. en:beractant -- r_associated #0: 20 / 0.465 -> en:moguisteine
    n1=en:beractant | n2=en:moguisteine | rel=r_associated | relid=0 | w=20
  222. en:beractant -- r_associated #0: 20 / 0.465 -> en:monoclonal ab
    n1=en:beractant | n2=en:monoclonal ab | rel=r_associated | relid=0 | w=20
  223. en:beractant -- r_associated #0: 20 / 0.465 -> en:monoclonal antibody agent
    n1=en:beractant | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=20
  224. en:beractant -- r_associated #0: 20 / 0.465 -> en:mucolytic agent
    n1=en:beractant | n2=en:mucolytic agent | rel=r_associated | relid=0 | w=20
  225. en:beractant -- r_associated #0: 20 / 0.465 -> en:nesosteine
    n1=en:beractant | n2=en:nesosteine | rel=r_associated | relid=0 | w=20
  226. en:beractant -- r_associated #0: 20 / 0.465 -> en:neurotransmitter
    n1=en:beractant | n2=en:neurotransmitter | rel=r_associated | relid=0 | w=20
  227. en:beractant -- r_associated #0: 20 / 0.465 -> en:ovine digoxin immune fab
    n1=en:beractant | n2=en:ovine digoxin immune fab | rel=r_associated | relid=0 | w=20
  228. en:beractant -- r_associated #0: 20 / 0.465 -> en:phenazopyridine + butabarbital + hyoscyamine
    n1=en:beractant | n2=en:phenazopyridine + butabarbital + hyoscyamine | rel=r_associated | relid=0 | w=20
  229. en:beractant -- r_associated #0: 20 / 0.465 -> en:recombinant cytokine
    n1=en:beractant | n2=en:recombinant cytokine | rel=r_associated | relid=0 | w=20
  230. en:beractant -- r_associated #0: 20 / 0.465 -> en:red yeast rice
    n1=en:beractant | n2=en:red yeast rice | rel=r_associated | relid=0 | w=20
  231. en:beractant -- r_associated #0: 20 / 0.465 -> en:respiratory form tyloxapol
    n1=en:beractant | n2=en:respiratory form tyloxapol | rel=r_associated | relid=0 | w=20
  232. en:beractant -- r_associated #0: 20 / 0.465 -> en:therapeutic autologous lymphocytes
    n1=en:beractant | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=20
  233. en:beractant -- r_associated #0: 20 / 0.465 -> en:vaccine, immunoglobulin, and/or antiserum
    n1=en:beractant | n2=en:vaccine, immunoglobulin, and/or antiserum | rel=r_associated | relid=0 | w=20
  234. en:beractant -- r_associated #0: 20 / 0.465 -> en:virus-specific cytotoxic t-lymphocytes
    n1=en:beractant | n2=en:virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  235. en:beractant -- r_associated #0: 20 / 0.465 -> farine animale
    n1=en:beractant | n2=farine animale | rel=r_associated | relid=0 | w=20
  236. en:beractant -- r_associated #0: 20 / 0.465 -> gène
    n1=en:beractant | n2=gène | rel=r_associated | relid=0 | w=20
  237. en:beractant -- r_associated #0: 20 / 0.465 -> gene
    n1=en:beractant | n2=gene | rel=r_associated | relid=0 | w=20
  238. en:beractant -- r_associated #0: 20 / 0.465 -> génique
    n1=en:beractant | n2=génique | rel=r_associated | relid=0 | w=20
  239. en:beractant -- r_associated #0: 20 / 0.465 -> gonadotrophine ménopausique humaine
    n1=en:beractant | n2=gonadotrophine ménopausique humaine | rel=r_associated | relid=0 | w=20
  240. en:beractant -- r_associated #0: 20 / 0.465 -> hormone gonadotrope ménopausique humaine
    n1=en:beractant | n2=hormone gonadotrope ménopausique humaine | rel=r_associated | relid=0 | w=20
  241. en:beractant -- r_associated #0: 20 / 0.465 -> immunotoxine
    n1=en:beractant | n2=immunotoxine | rel=r_associated | relid=0 | w=20
  242. en:beractant -- r_associated #0: 20 / 0.465 -> interleukine 2
    n1=en:beractant | n2=interleukine 2 | rel=r_associated | relid=0 | w=20
  243. en:beractant -- r_associated #0: 20 / 0.465 -> monoclonal antibody
    n1=en:beractant | n2=monoclonal antibody | rel=r_associated | relid=0 | w=20
  244. en:beractant -- r_associated #0: 20 / 0.465 -> neurotransmetteur
    n1=en:beractant | n2=neurotransmetteur | rel=r_associated | relid=0 | w=20
  245. en:beractant -- r_associated #0: 20 / 0.465 -> protein
    n1=en:beractant | n2=protein | rel=r_associated | relid=0 | w=20
  246. en:beractant -- r_associated #0: 20 / 0.465 -> proteine
    n1=en:beractant | n2=proteine | rel=r_associated | relid=0 | w=20
  247. en:beractant -- r_associated #0: 20 / 0.465 -> vaccin microbien
    n1=en:beractant | n2=vaccin microbien | rel=r_associated | relid=0 | w=20
  248. en:beractant -- r_associated #0: 20 / 0.465 -> vaccine
    n1=en:beractant | n2=vaccine | rel=r_associated | relid=0 | w=20
  249. en:beractant -- r_associated #0: 20 / 0.465 -> variole de la vache
    n1=en:beractant | n2=variole de la vache | rel=r_associated | relid=0 | w=20
  250. en:beractant -- r_associated #0: 1 / 0.023 -> en:organic chemical
    n1=en:beractant | n2=en:organic chemical | rel=r_associated | relid=0 | w=1
≈ 219 relations entrantes

  1. protein --- r_associated #0: 825 --> en:beractant
    n1=protein | n2=en:beractant | rel=r_associated | relid=0 | w=825
  2. protéine --- r_associated #0: 798.95 --> en:beractant
    n1=protéine | n2=en:beractant | rel=r_associated | relid=0 | w=798.95
  3. en:protein --- r_associated #0: 798.67 --> en:beractant
    n1=en:protein | n2=en:beractant | rel=r_associated | relid=0 | w=798.67
  4. proteine --- r_associated #0: 305 --> en:beractant
    n1=proteine | n2=en:beractant | rel=r_associated | relid=0 | w=305
  5. en:biological agent --- r_associated #0: 155 --> en:beractant
    n1=en:biological agent | n2=en:beractant | rel=r_associated | relid=0 | w=155
  6. agent biologique --- r_associated #0: 153 --> en:beractant
    n1=agent biologique | n2=en:beractant | rel=r_associated | relid=0 | w=153
  7. en:human menopausal gonadotropin --- r_associated #0: 144 --> en:beractant
    n1=en:human menopausal gonadotropin | n2=en:beractant | rel=r_associated | relid=0 | w=144
  8. gonadotrophine ménopausique humaine --- r_associated #0: 140 --> en:beractant
    n1=gonadotrophine ménopausique humaine | n2=en:beractant | rel=r_associated | relid=0 | w=140
  9. anticorps monoclonal --- r_associated #0: 139 --> en:beractant
    n1=anticorps monoclonal | n2=en:beractant | rel=r_associated | relid=0 | w=139
  10. en:monoclonal antibody --- r_associated #0: 138 --> en:beractant
    n1=en:monoclonal antibody | n2=en:beractant | rel=r_associated | relid=0 | w=138
  11. monoclonal antibody --- r_associated #0: 125 --> en:beractant
    n1=monoclonal antibody | n2=en:beractant | rel=r_associated | relid=0 | w=125
  12. en:drug allergy --- r_associated #0: 115 --> en:beractant
    n1=en:drug allergy | n2=en:beractant | rel=r_associated | relid=0 | w=115
  13. allergie aux médicaments --- r_associated #0: 112 --> en:beractant
    n1=allergie aux médicaments | n2=en:beractant | rel=r_associated | relid=0 | w=112
  14. allergie médicamenteuse --- r_associated #0: 107 --> en:beractant
    n1=allergie médicamenteuse | n2=en:beractant | rel=r_associated | relid=0 | w=107
  15. allergie à un médicament --- r_associated #0: 100 --> en:beractant
    n1=allergie à un médicament | n2=en:beractant | rel=r_associated | relid=0 | w=100
  16. acétylcystéine --- r_associated #0: 89 --> en:beractant
    n1=acétylcystéine | n2=en:beractant | rel=r_associated | relid=0 | w=89
  17. en:acetylcysteine --- r_associated #0: 85 --> en:beractant
    n1=en:acetylcysteine | n2=en:beractant | rel=r_associated | relid=0 | w=85
  18. en:ambroxol --- r_associated #0: 75 --> en:beractant
    n1=en:ambroxol | n2=en:beractant | rel=r_associated | relid=0 | w=75
  19. ambroxol --- r_associated #0: 71 --> en:beractant
    n1=ambroxol | n2=en:beractant | rel=r_associated | relid=0 | w=71
  20. farine animale --- r_associated #0: 59 --> en:beractant
    n1=farine animale | n2=en:beractant | rel=r_associated | relid=0 | w=59
  21. en:bone meal --- r_associated #0: 56 --> en:beractant
    n1=en:bone meal | n2=en:beractant | rel=r_associated | relid=0 | w=56
  22. Anticorps monoclonal --- r_associated #0: 50 --> en:beractant
    n1=Anticorps monoclonal | n2=en:beractant | rel=r_associated | relid=0 | w=50
  23. en:gene --- r_associated #0: 46 --> en:beractant
    n1=en:gene | n2=en:beractant | rel=r_associated | relid=0 | w=46
  24. en:anti-asthmatic agent --- r_associated #0: 43 --> en:beractant
    n1=en:anti-asthmatic agent | n2=en:beractant | rel=r_associated | relid=0 | w=43
  25. en:dendritic cell-precision multiple antigen t-lymphocytes --- r_associated #0: 43 --> en:beractant
    n1=en:dendritic cell-precision multiple antigen t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=43
  26. en:recombinant human serum amyloid p/pentraxin 2 --- r_associated #0: 43 --> en:beractant
    n1=en:recombinant human serum amyloid p/pentraxin 2 | n2=en:beractant | rel=r_associated | relid=0 | w=43
  27. gene --- r_associated #0: 43 --> en:beractant
    n1=gene | n2=en:beractant | rel=r_associated | relid=0 | w=43
  28. en:belladonna alkaloid- and butabarbital-containing product --- r_associated #0: 41 --> en:beractant
    n1=en:belladonna alkaloid- and butabarbital-containing product | n2=en:beractant | rel=r_associated | relid=0 | w=41
  29. en:human menopausal gonadotrophin --- r_associated #0: 40 --> en:beractant
    n1=en:human menopausal gonadotrophin | n2=en:beractant | rel=r_associated | relid=0 | w=40
  30. en:human placenta hydrolysate --- r_associated #0: 40 --> en:beractant
    n1=en:human placenta hydrolysate | n2=en:beractant | rel=r_associated | relid=0 | w=40
  31. agent mucolytique --- r_associated #0: 39 --> en:beractant
    n1=agent mucolytique | n2=en:beractant | rel=r_associated | relid=0 | w=39
  32. en:mucolytic agent --- r_associated #0: 37 --> en:beractant
    n1=en:mucolytic agent | n2=en:beractant | rel=r_associated | relid=0 | w=37
  33. extrait d'un surfactant de poumon de veau modifié --- r_associated #0: 37 --> en:beractant
    n1=extrait d'un surfactant de poumon de veau modifié | n2=en:beractant | rel=r_associated | relid=0 | w=37
  34. hormone gonadotrope ménopausique humaine --- r_associated #0: 37 --> en:beractant
    n1=hormone gonadotrope ménopausique humaine | n2=en:beractant | rel=r_associated | relid=0 | w=37
  35. en:survanta intratracheal product --- r_associated #0: 36 --> en:beractant
    n1=en:survanta intratracheal product | n2=en:beractant | rel=r_associated | relid=0 | w=36
  36. en:4scar-gd2-modified t-lymphocytes --- r_associated #0: 35 --> en:beractant
    n1=en:4scar-gd2-modified t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=35
  37. en:biosimilar pharmaceuticals --- r_associated #0: 35 --> en:beractant
    n1=en:biosimilar pharmaceuticals | n2=en:beractant | rel=r_associated | relid=0 | w=35
  38. en:bos taurus hip joint preparation --- r_associated #0: 35 --> en:beractant
    n1=en:bos taurus hip joint preparation | n2=en:beractant | rel=r_associated | relid=0 | w=35
  39. en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride --- r_associated #0: 35 --> en:beractant
    n1=en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride | n2=en:beractant | rel=r_associated | relid=0 | w=35
  40. en:cathelicidin ll-37 --- r_associated #0: 35 --> en:beractant
    n1=en:cathelicidin ll-37 | n2=en:beractant | rel=r_associated | relid=0 | w=35
  41. en:enzyme replacement or supplement agent --- r_associated #0: 35 --> en:beractant
    n1=en:enzyme replacement or supplement agent | n2=en:beractant | rel=r_associated | relid=0 | w=35
  42. en:fap-specific cd8-positive t cells --- r_associated #0: 35 --> en:beractant
    n1=en:fap-specific cd8-positive t cells | n2=en:beractant | rel=r_associated | relid=0 | w=35
  43. en:meat and bone flour --- r_associated #0: 35 --> en:beractant
    n1=en:meat and bone flour | n2=en:beractant | rel=r_associated | relid=0 | w=35
  44. en:monoclonal antibody agent --- r_associated #0: 35 --> en:beractant
    n1=en:monoclonal antibody agent | n2=en:beractant | rel=r_associated | relid=0 | w=35
  45. en:phenazopyridine + butabarbital + hyoscyamine --- r_associated #0: 35 --> en:beractant
    n1=en:phenazopyridine + butabarbital + hyoscyamine | n2=en:beractant | rel=r_associated | relid=0 | w=35
  46. en:red yeast rice --- r_associated #0: 35 --> en:beractant
    n1=en:red yeast rice | n2=en:beractant | rel=r_associated | relid=0 | w=35
  47. en:stepronin --- r_associated #0: 35 --> en:beractant
    n1=en:stepronin | n2=en:beractant | rel=r_associated | relid=0 | w=35
  48. en:anthrax vaccine adsorbed --- r_associated #0: 34 --> en:beractant
    n1=en:anthrax vaccine adsorbed | n2=en:beractant | rel=r_associated | relid=0 | w=34
  49. en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 34 --> en:beractant
    n1=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=34
  50. en:autologous mesenchymal stem cells apceth_101 --- r_associated #0: 34 --> en:beractant
    n1=en:autologous mesenchymal stem cells apceth_101 | n2=en:beractant | rel=r_associated | relid=0 | w=34
  51. en:bluefish allergenic extract --- r_associated #0: 34 --> en:beractant
    n1=en:bluefish allergenic extract | n2=en:beractant | rel=r_associated | relid=0 | w=34
  52. en:brovanexine --- r_associated #0: 34 --> en:beractant
    n1=en:brovanexine | n2=en:beractant | rel=r_associated | relid=0 | w=34
  53. en:dornase alfa --- r_associated #0: 34 --> en:beractant
    n1=en:dornase alfa | n2=en:beractant | rel=r_associated | relid=0 | w=34
  54. en:erdosteine --- r_associated #0: 34 --> en:beractant
    n1=en:erdosteine | n2=en:beractant | rel=r_associated | relid=0 | w=34
  55. en:interleukin-2 --- r_associated #0: 34 --> en:beractant
    n1=en:interleukin-2 | n2=en:beractant | rel=r_associated | relid=0 | w=34
  56. en:live yeast cell derivative --- r_associated #0: 34 --> en:beractant
    n1=en:live yeast cell derivative | n2=en:beractant | rel=r_associated | relid=0 | w=34
  57. en:vaccine, immunoglobulin, and/or antiserum --- r_associated #0: 34 --> en:beractant
    n1=en:vaccine, immunoglobulin, and/or antiserum | n2=en:beractant | rel=r_associated | relid=0 | w=34
  58. en:virus-specific cytotoxic t-lymphocytes --- r_associated #0: 34 --> en:beractant
    n1=en:virus-specific cytotoxic t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=34
  59. antigène --- r_associated #0: 33 --> en:beractant
    n1=antigène | n2=en:beractant | rel=r_associated | relid=0 | w=33
  60. en:colony stimulating factor --- r_associated #0: 32 --> en:beractant
    n1=en:colony stimulating factor | n2=en:beractant | rel=r_associated | relid=0 | w=32
  61. en:danthron and poloxamer 188 product --- r_associated #0: 32 --> en:beractant
    n1=en:danthron and poloxamer 188 product | n2=en:beractant | rel=r_associated | relid=0 | w=32
  62. en:gene transfer or gene delivery agent --- r_associated #0: 32 --> en:beractant
    n1=en:gene transfer or gene delivery agent | n2=en:beractant | rel=r_associated | relid=0 | w=32
  63. en:green soap --- r_associated #0: 32 --> en:beractant
    n1=en:green soap | n2=en:beractant | rel=r_associated | relid=0 | w=32
  64. en:hydrochloride, bromhexine --- r_associated #0: 32 --> en:beractant
    n1=en:hydrochloride, bromhexine | n2=en:beractant | rel=r_associated | relid=0 | w=32
  65. en:mecysteine --- r_associated #0: 32 --> en:beractant
    n1=en:mecysteine | n2=en:beractant | rel=r_associated | relid=0 | w=32
  66. en:surfactant activity [moa] --- r_associated #0: 32 --> en:beractant
    n1=en:surfactant activity [moa] | n2=en:beractant | rel=r_associated | relid=0 | w=32
  67. en:adoptive cell therapy agent --- r_associated #0: 31 --> en:beractant
    n1=en:adoptive cell therapy agent | n2=en:beractant | rel=r_associated | relid=0 | w=31
  68. en:alveolar surface tension reduction [pe] --- r_associated #0: 31 --> en:beractant
    n1=en:alveolar surface tension reduction [pe] | n2=en:beractant | rel=r_associated | relid=0 | w=31
  69. en:antigen --- r_associated #0: 31 --> en:beractant
    n1=en:antigen | n2=en:beractant | rel=r_associated | relid=0 | w=31
  70. en:autologous interferon-producing killer dendritic cells --- r_associated #0: 31 --> en:beractant
    n1=en:autologous interferon-producing killer dendritic cells | n2=en:beractant | rel=r_associated | relid=0 | w=31
  71. en:blood derivative product --- r_associated #0: 31 --> en:beractant
    n1=en:blood derivative product | n2=en:beractant | rel=r_associated | relid=0 | w=31
  72. en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs --- r_associated #0: 31 --> en:beractant
    n1=en:c46/ccr5/p140k lentiviral vector-transduced autologous hspcs | n2=en:beractant | rel=r_associated | relid=0 | w=31
  73. en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells --- r_associated #0: 31 --> en:beractant
    n1=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | n2=en:beractant | rel=r_associated | relid=0 | w=31
  74. en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes --- r_associated #0: 31 --> en:beractant
    n1=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=31
  75. en:transduction gene --- r_associated #0: 31 --> en:beractant
    n1=en:transduction gene | n2=en:beractant | rel=r_associated | relid=0 | w=31
  76. génique --- r_associated #0: 31 --> en:beractant
    n1=génique | n2=en:beractant | rel=r_associated | relid=0 | w=31
  77. interleukine 2 --- r_associated #0: 31 --> en:beractant
    n1=interleukine 2 | n2=en:beractant | rel=r_associated | relid=0 | w=31
  78. cow-pox --- r_associated #0: 30 --> en:beractant
    n1=cow-pox | n2=en:beractant | rel=r_associated | relid=0 | w=30
  79. cowpox --- r_associated #0: 30 --> en:beractant
    n1=cowpox | n2=en:beractant | rel=r_associated | relid=0 | w=30
  80. en:acellular cadaveric dermal matrix --- r_associated #0: 30 --> en:beractant
    n1=en:acellular cadaveric dermal matrix | n2=en:beractant | rel=r_associated | relid=0 | w=30
  81. en:alpha-1-proteinase inhibitor human --- r_associated #0: 30 --> en:beractant
    n1=en:alpha-1-proteinase inhibitor human | n2=en:beractant | rel=r_associated | relid=0 | w=30
  82. en:anti-prolactin receptor antibody lfa102 --- r_associated #0: 30 --> en:beractant
    n1=en:anti-prolactin receptor antibody lfa102 | n2=en:beractant | rel=r_associated | relid=0 | w=30
  83. en:colfosceril palmitate --- r_associated #0: 30 --> en:beractant
    n1=en:colfosceril palmitate | n2=en:beractant | rel=r_associated | relid=0 | w=30
  84. en:cowpox --- r_associated #0: 30 --> en:beractant
    n1=en:cowpox | n2=en:beractant | rel=r_associated | relid=0 | w=30
  85. en:dehydrated human amnion/chorion membrane --- r_associated #0: 30 --> en:beractant
    n1=en:dehydrated human amnion/chorion membrane | n2=en:beractant | rel=r_associated | relid=0 | w=30
  86. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 30 --> en:beractant
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:beractant | rel=r_associated | relid=0 | w=30
  87. en:recombinant growth factor --- r_associated #0: 30 --> en:beractant
    n1=en:recombinant growth factor | n2=en:beractant | rel=r_associated | relid=0 | w=30
  88. en:thrombopoietin receptor agonist lgd-4665 --- r_associated #0: 30 --> en:beractant
    n1=en:thrombopoietin receptor agonist lgd-4665 | n2=en:beractant | rel=r_associated | relid=0 | w=30
  89. en:vaccine --- r_associated #0: 30 --> en:beractant
    n1=en:vaccine | n2=en:beractant | rel=r_associated | relid=0 | w=30
  90. vaccin microbien --- r_associated #0: 30 --> en:beractant
    n1=vaccin microbien | n2=en:beractant | rel=r_associated | relid=0 | w=30
  91. vaccine --- r_associated #0: 30 --> en:beractant
    n1=vaccine | n2=en:beractant | rel=r_associated | relid=0 | w=30
  92. en:artificial lung expanding compound --- r_associated #0: 29 --> en:beractant
    n1=en:artificial lung expanding compound | n2=en:beractant | rel=r_associated | relid=0 | w=29
  93. en:cells [chemical/ingredient] --- r_associated #0: 29 --> en:beractant
    n1=en:cells [chemical/ingredient] | n2=en:beractant | rel=r_associated | relid=0 | w=29
  94. en:cord blood-derived expanded natural killer cells pnk-007 --- r_associated #0: 29 --> en:beractant
    n1=en:cord blood-derived expanded natural killer cells pnk-007 | n2=en:beractant | rel=r_associated | relid=0 | w=29
  95. en:denileukin diftitox --- r_associated #0: 29 --> en:beractant
    n1=en:denileukin diftitox | n2=en:beractant | rel=r_associated | relid=0 | w=29
  96. en:eprazinone --- r_associated #0: 29 --> en:beractant
    n1=en:eprazinone | n2=en:beractant | rel=r_associated | relid=0 | w=29
  97. en:human immunoglobulin a --- r_associated #0: 29 --> en:beractant
    n1=en:human immunoglobulin a | n2=en:beractant | rel=r_associated | relid=0 | w=29
  98. en:immunotoxin --- r_associated #0: 29 --> en:beractant
    n1=en:immunotoxin | n2=en:beractant | rel=r_associated | relid=0 | w=29
  99. en:mirasol-treated allogeneic platelets --- r_associated #0: 29 --> en:beractant
    n1=en:mirasol-treated allogeneic platelets | n2=en:beractant | rel=r_associated | relid=0 | w=29
  100. en:therapeutic angiotensin-(1-7) --- r_associated #0: 29 --> en:beractant
    n1=en:therapeutic angiotensin-(1-7) | n2=en:beractant | rel=r_associated | relid=0 | w=29
  101. extrait de poumon de bovin --- r_associated #0: 29 --> en:beractant
    n1=extrait de poumon de bovin | n2=en:beractant | rel=r_associated | relid=0 | w=29
  102. immunotoxine --- r_associated #0: 29 --> en:beractant
    n1=immunotoxine | n2=en:beractant | rel=r_associated | relid=0 | w=29
  103. en:anti-tumor necrosis factor alpha drug --- r_associated #0: 28 --> en:beractant
    n1=en:anti-tumor necrosis factor alpha drug | n2=en:beractant | rel=r_associated | relid=0 | w=28
  104. en:bcma-specific car-expressing t lymphocytes --- r_associated #0: 28 --> en:beractant
    n1=en:bcma-specific car-expressing t lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=28
  105. en:beractant intratracheal suspension --- r_associated #0: 28 --> en:beractant
    n1=en:beractant intratracheal suspension | n2=en:beractant | rel=r_associated | relid=0 | w=28
  106. en:blood group antigen carrier --- r_associated #0: 28 --> en:beractant
    n1=en:blood group antigen carrier | n2=en:beractant | rel=r_associated | relid=0 | w=28
  107. en:bromodiphenhydramine+codeine --- r_associated #0: 28 --> en:beractant
    n1=en:bromodiphenhydramine+codeine | n2=en:beractant | rel=r_associated | relid=0 | w=28
  108. en:domiodol --- r_associated #0: 28 --> en:beractant
    n1=en:domiodol | n2=en:beractant | rel=r_associated | relid=0 | w=28
  109. en:genetically engineered hematopoietic stem progenitor cells --- r_associated #0: 28 --> en:beractant
    n1=en:genetically engineered hematopoietic stem progenitor cells | n2=en:beractant | rel=r_associated | relid=0 | w=28
  110. en:letosteine --- r_associated #0: 28 --> en:beractant
    n1=en:letosteine | n2=en:beractant | rel=r_associated | relid=0 | w=28
  111. en:monoclonal ab --- r_associated #0: 28 --> en:beractant
    n1=en:monoclonal ab | n2=en:beractant | rel=r_associated | relid=0 | w=28
  112. en:neltenexine --- r_associated #0: 28 --> en:beractant
    n1=en:neltenexine | n2=en:beractant | rel=r_associated | relid=0 | w=28
  113. en:neurotransmitter --- r_associated #0: 28 --> en:beractant
    n1=en:neurotransmitter | n2=en:beractant | rel=r_associated | relid=0 | w=28
  114. en:respiratory form tyloxapol --- r_associated #0: 28 --> en:beractant
    n1=en:respiratory form tyloxapol | n2=en:beractant | rel=r_associated | relid=0 | w=28
  115. en:tasuldine --- r_associated #0: 28 --> en:beractant
    n1=en:tasuldine | n2=en:beractant | rel=r_associated | relid=0 | w=28
  116. surfactant ta --- r_associated #0: 28 --> en:beractant
    n1=surfactant ta | n2=en:beractant | rel=r_associated | relid=0 | w=28
  117. en:anti-cd22 car-expressing t lymphocytes --- r_associated #0: 27 --> en:beractant
    n1=en:anti-cd22 car-expressing t lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=27
  118. en:autologous pbmcs in gm-csf --- r_associated #0: 27 --> en:beractant
    n1=en:autologous pbmcs in gm-csf | n2=en:beractant | rel=r_associated | relid=0 | w=27
  119. en:beractant intratracheal suspension [survanta] --- r_associated #0: 27 --> en:beractant
    n1=en:beractant intratracheal suspension [survanta] | n2=en:beractant | rel=r_associated | relid=0 | w=27
  120. en:colfosceril --- r_associated #0: 27 --> en:beractant
    n1=en:colfosceril | n2=en:beractant | rel=r_associated | relid=0 | w=27
  121. en:filgrastim-primed peripheral blood progenitor cells --- r_associated #0: 27 --> en:beractant
    n1=en:filgrastim-primed peripheral blood progenitor cells | n2=en:beractant | rel=r_associated | relid=0 | w=27
  122. en:recombinant cytokine --- r_associated #0: 27 --> en:beractant
    n1=en:recombinant cytokine | n2=en:beractant | rel=r_associated | relid=0 | w=27
  123. en:therapeutic autologous lymphocytes --- r_associated #0: 27 --> en:beractant
    n1=en:therapeutic autologous lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=27
  124. en:ularitide --- r_associated #0: 27 --> en:beractant
    n1=en:ularitide | n2=en:beractant | rel=r_associated | relid=0 | w=27
  125. neurotransmetteur --- r_associated #0: 27 --> en:beractant
    n1=neurotransmetteur | n2=en:beractant | rel=r_associated | relid=0 | w=27
  126. variole de la vache --- r_associated #0: 27 --> en:beractant
    n1=variole de la vache | n2=en:beractant | rel=r_associated | relid=0 | w=27
  127. béractant --- r_associated #0: 26 --> en:beractant
    n1=béractant | n2=en:beractant | rel=r_associated | relid=0 | w=26
  128. en:3d-expanded placenta-derived cells plx-r18 --- r_associated #0: 26 --> en:beractant
    n1=en:3d-expanded placenta-derived cells plx-r18 | n2=en:beractant | rel=r_associated | relid=0 | w=26
  129. en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 26 --> en:beractant
    n1=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=26
  130. en:brimonidine + timolol --- r_associated #0: 26 --> en:beractant
    n1=en:brimonidine + timolol | n2=en:beractant | rel=r_associated | relid=0 | w=26
  131. en:brompheniramine + pseudoephedrine --- r_associated #0: 26 --> en:beractant
    n1=en:brompheniramine + pseudoephedrine | n2=en:beractant | rel=r_associated | relid=0 | w=26
  132. en:dembrexine --- r_associated #0: 26 --> en:beractant
    n1=en:dembrexine | n2=en:beractant | rel=r_associated | relid=0 | w=26
  133. en:dr5-targeting tetrameric nanobody agonist tas266 --- r_associated #0: 26 --> en:beractant
    n1=en:dr5-targeting tetrameric nanobody agonist tas266 | n2=en:beractant | rel=r_associated | relid=0 | w=26
  134. en:dual variable domain immunoglobulin abt-165 --- r_associated #0: 26 --> en:beractant
    n1=en:dual variable domain immunoglobulin abt-165 | n2=en:beractant | rel=r_associated | relid=0 | w=26
  135. en:medicinal allergy --- r_associated #0: 26 --> en:beractant
    n1=en:medicinal allergy | n2=en:beractant | rel=r_associated | relid=0 | w=26
  136. en:moguisteine --- r_associated #0: 26 --> en:beractant
    n1=en:moguisteine | n2=en:beractant | rel=r_associated | relid=0 | w=26
  137. en:nesosteine --- r_associated #0: 26 --> en:beractant
    n1=en:nesosteine | n2=en:beractant | rel=r_associated | relid=0 | w=26
  138. en:ovine digoxin immune fab --- r_associated #0: 26 --> en:beractant
    n1=en:ovine digoxin immune fab | n2=en:beractant | rel=r_associated | relid=0 | w=26
  139. en:telmesteine --- r_associated #0: 26 --> en:beractant
    n1=en:telmesteine | n2=en:beractant | rel=r_associated | relid=0 | w=26
  140. gène --- r_associated #0: 26 --> en:beractant
    n1=gène | n2=en:beractant | rel=r_associated | relid=0 | w=26
  141. en:plant exudates --- r_associated #0: 25 --> en:beractant
    n1=en:plant exudates | n2=en:beractant | rel=r_associated | relid=0 | w=25
  142. surfactant tokyo-akita --- r_associated #0: 25 --> en:beractant
    n1=surfactant tokyo-akita | n2=en:beractant | rel=r_associated | relid=0 | w=25
  143. gonadotrophine de femmes ménopausées --- r_associated #0: 24 --> en:beractant
    n1=gonadotrophine de femmes ménopausées | n2=en:beractant | rel=r_associated | relid=0 | w=24
  144. protide --- r_associated #0: 23 --> en:beractant
    n1=protide | n2=en:beractant | rel=r_associated | relid=0 | w=23
  145. vaccinal --- r_associated #0: 21 --> en:beractant
    n1=vaccinal | n2=en:beractant | rel=r_associated | relid=0 | w=21
  146. en:acetylcysteine 200 mg/ml inhalant solution --- r_associated #0: 20 --> en:beractant
    n1=en:acetylcysteine 200 mg/ml inhalant solution | n2=en:beractant | rel=r_associated | relid=0 | w=20
  147. en:adamexine --- r_associated #0: 20 --> en:beractant
    n1=en:adamexine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  148. en:alonacic --- r_associated #0: 20 --> en:beractant
    n1=en:alonacic | n2=en:beractant | rel=r_associated | relid=0 | w=20
  149. en:antisense oligonucleotides --- r_associated #0: 20 --> en:beractant
    n1=en:antisense oligonucleotides | n2=en:beractant | rel=r_associated | relid=0 | w=20
  150. en:antitussive agent --- r_associated #0: 20 --> en:beractant
    n1=en:antitussive agent | n2=en:beractant | rel=r_associated | relid=0 | w=20
  151. en:autologous cd34-positive hematopoietic progenitor cells --- r_associated #0: 20 --> en:beractant
    n1=en:autologous cd34-positive hematopoietic progenitor cells | n2=en:beractant | rel=r_associated | relid=0 | w=20
  152. en:biological control agents --- r_associated #0: 20 --> en:beractant
    n1=en:biological control agents | n2=en:beractant | rel=r_associated | relid=0 | w=20
  153. en:biological warfare agents --- r_associated #0: 20 --> en:beractant
    n1=en:biological warfare agents | n2=en:beractant | rel=r_associated | relid=0 | w=20
  154. en:bovine pituitary extract --- r_associated #0: 20 --> en:beractant
    n1=en:bovine pituitary extract | n2=en:beractant | rel=r_associated | relid=0 | w=20
  155. en:brovanexine hydrochloride --- r_associated #0: 20 --> en:beractant
    n1=en:brovanexine hydrochloride | n2=en:beractant | rel=r_associated | relid=0 | w=20
  156. en:calfactant --- r_associated #0: 20 --> en:beractant
    n1=en:calfactant | n2=en:beractant | rel=r_associated | relid=0 | w=20
  157. en:cartasteine --- r_associated #0: 20 --> en:beractant
    n1=en:cartasteine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  158. en:cd138car-cd137/tcrzeta-expressing t lymphocytes --- r_associated #0: 20 --> en:beractant
    n1=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=20
  159. en:cistinexine --- r_associated #0: 20 --> en:beractant
    n1=en:cistinexine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  160. en:danosteine --- r_associated #0: 20 --> en:beractant
    n1=en:danosteine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  161. en:denufosol --- r_associated #0: 20 --> en:beractant
    n1=en:denufosol | n2=en:beractant | rel=r_associated | relid=0 | w=20
  162. en:donor regulatory t-lymphocytes --- r_associated #0: 20 --> en:beractant
    n1=en:donor regulatory t-lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=20
  163. en:expanded umbilical cord blood product hsc835 --- r_associated #0: 20 --> en:beractant
    n1=en:expanded umbilical cord blood product hsc835 | n2=en:beractant | rel=r_associated | relid=0 | w=20
  164. en:fudosteine --- r_associated #0: 20 --> en:beractant
    n1=en:fudosteine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  165. en:gene therapy agent --- r_associated #0: 20 --> en:beractant
    n1=en:gene therapy agent | n2=en:beractant | rel=r_associated | relid=0 | w=20
  166. en:her2-targeting antibody fc fragment fs102 --- r_associated #0: 20 --> en:beractant
    n1=en:her2-targeting antibody fc fragment fs102 | n2=en:beractant | rel=r_associated | relid=0 | w=20
  167. en:hsp70-peptide tkd/il-2-activated autologous natural killer cells --- r_associated #0: 20 --> en:beractant
    n1=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | n2=en:beractant | rel=r_associated | relid=0 | w=20
  168. en:human immunoglobulin g --- r_associated #0: 20 --> en:beractant
    n1=en:human immunoglobulin g | n2=en:beractant | rel=r_associated | relid=0 | w=20
  169. en:interferon beta-secreting mesenchymal stem cells --- r_associated #0: 20 --> en:beractant
    n1=en:interferon beta-secreting mesenchymal stem cells | n2=en:beractant | rel=r_associated | relid=0 | w=20
  170. en:lenti-d/abcd1-transduced autologous hematopoietic stem cells --- r_associated #0: 20 --> en:beractant
    n1=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | n2=en:beractant | rel=r_associated | relid=0 | w=20
  171. en:luspatercept --- r_associated #0: 20 --> en:beractant
    n1=en:luspatercept | n2=en:beractant | rel=r_associated | relid=0 | w=20
  172. en:lymphoma taa-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> en:beractant
    n1=en:lymphoma taa-specific cytotoxic t lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=20
  173. en:ny-eso-1-specific cd4-positive t lymphocytes --- r_associated #0: 20 --> en:beractant
    n1=en:ny-eso-1-specific cd4-positive t lymphocytes | n2=en:beractant | rel=r_associated | relid=0 | w=20
  174. en:omonasteine --- r_associated #0: 20 --> en:beractant
    n1=en:omonasteine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  175. en:oncolytic virus --- r_associated #0: 20 --> en:beractant
    n1=en:oncolytic virus | n2=en:beractant | rel=r_associated | relid=0 | w=20
  176. en:oxabrexine --- r_associated #0: 20 --> en:beractant
    n1=en:oxabrexine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  177. en:picibanil --- r_associated #0: 20 --> en:beractant
    n1=en:picibanil | n2=en:beractant | rel=r_associated | relid=0 | w=20
  178. en:plant nectar --- r_associated #0: 20 --> en:beractant
    n1=en:plant nectar | n2=en:beractant | rel=r_associated | relid=0 | w=20
  179. en:poractant alfa --- r_associated #0: 20 --> en:beractant
    n1=en:poractant alfa | n2=en:beractant | rel=r_associated | relid=0 | w=20
  180. en:prenisteine --- r_associated #0: 20 --> en:beractant
    n1=en:prenisteine | n2=en:beractant | rel=r_associated | relid=0 | w=20
  181. en:recombinant cell-surface anchored sialidase das181 --- r_associated #0: 20 --> en:beractant
    n1=en:recombinant cell-surface anchored sialidase das181 | n2=en:beractant | rel=r_associated | relid=0 | w=20
  182. en:serum-derived bovine immunoglobulin protein isolate --- r_associated #0: 20 --> en:beractant
    n1=en:serum-derived bovine immunoglobulin protein isolate | n2=en:beractant | rel=r_associated | relid=0 | w=20
  183. Agent biologique --- r_associated #0: 15 --> en:beractant
    n1=Agent biologique | n2=en:beractant | rel=r_associated | relid=0 | w=15
  184. Cowper (glande de) --- r_associated #0: 15 --> en:beractant
    n1=Cowper (glande de) | n2=en:beractant | rel=r_associated | relid=0 | w=15
  185. Farine animale --- r_associated #0: 15 --> en:beractant
    n1=Farine animale | n2=en:beractant | rel=r_associated | relid=0 | w=15
  186. PROTEIN --- r_associated #0: 15 --> en:beractant
    n1=PROTEIN | n2=en:beractant | rel=r_associated | relid=0 | w=15
  187. Protéine --- r_associated #0: 15 --> en:beractant
    n1=Protéine | n2=en:beractant | rel=r_associated | relid=0 | w=15
  188. antigen --- r_associated #0: 15 --> en:beractant
    n1=antigen | n2=en:beractant | rel=r_associated | relid=0 | w=15
  189. produit dérivé du sang --- r_associated #0: 15 --> en:beractant
    n1=produit dérivé du sang | n2=en:beractant | rel=r_associated | relid=0 | w=15
  190. Acétylcystéine --- r_associated #0: 10 --> en:beractant
    n1=Acétylcystéine | n2=en:beractant | rel=r_associated | relid=0 | w=10
  191. Ag
    (antigène)
     --- r_associated #0: 10 --> en:beractant
    n1=Ag
    (antigène)
    | n2=en:beractant | rel=r_associated | relid=0 | w=10
  192. Ambroxol --- r_associated #0: 10 --> en:beractant
    n1=Ambroxol | n2=en:beractant | rel=r_associated | relid=0 | w=10
  193. Génique --- r_associated #0: 10 --> en:beractant
    n1=Génique | n2=en:beractant | rel=r_associated | relid=0 | w=10
  194. IL-2 --- r_associated #0: 10 --> en:beractant
    n1=IL-2 | n2=en:beractant | rel=r_associated | relid=0 | w=10
  195. Neurotransmetteur --- r_associated #0: 10 --> en:beractant
    n1=Neurotransmetteur | n2=en:beractant | rel=r_associated | relid=0 | w=10
  196. Protein --- r_associated #0: 10 --> en:beractant
    n1=Protein | n2=en:beractant | rel=r_associated | relid=0 | w=10
  197. Protée (syndrome de) --- r_associated #0: 10 --> en:beractant
    n1=Protée (syndrome de) | n2=en:beractant | rel=r_associated | relid=0 | w=10
  198. en:Cowper 's gland --- r_associated #0: 10 --> en:beractant
    n1=en:Cowper 's gland | n2=en:beractant | rel=r_associated | relid=0 | w=10
  199. en:cow-pox --- r_associated #0: 10 --> en:beractant
    n1=en:cow-pox | n2=en:beractant | rel=r_associated | relid=0 | w=10
  200. en:proteid --- r_associated #0: 10 --> en:beractant
    n1=en:proteid | n2=en:beractant | rel=r_associated | relid=0 | w=10
  201. en:protide --- r_associated #0: 10 --> en:beractant
    n1=en:protide | n2=en:beractant | rel=r_associated | relid=0 | w=10
  202. en:vaccinal --- r_associated #0: 10 --> en:beractant
    n1=en:vaccinal | n2=en:beractant | rel=r_associated | relid=0 | w=10
  203. géniculé (ganglion) --- r_associated #0: 10 --> en:beractant
    n1=géniculé (ganglion) | n2=en:beractant | rel=r_associated | relid=0 | w=10
  204. protidique --- r_associated #0: 10 --> en:beractant
    n1=protidique | n2=en:beractant | rel=r_associated | relid=0 | w=10
  205. cowperite --- r_associated #0: 5 --> en:beractant
    n1=cowperite | n2=en:beractant | rel=r_associated | relid=0 | w=5
  206. cowpox virus --- r_associated #0: 5 --> en:beractant
    n1=cowpox virus | n2=en:beractant | rel=r_associated | relid=0 | w=5
  207. en protéines --- r_associated #0: 5 --> en:beractant
    n1=en protéines | n2=en:beractant | rel=r_associated | relid=0 | w=5
  208. interféron (traitement par l') --- r_associated #0: 5 --> en:beractant
    n1=interféron (traitement par l') | n2=en:beractant | rel=r_associated | relid=0 | w=5
  209. lymphocytes T CD4-positifs spécifiques de NY-ESO-1 --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T CD4-positifs spécifiques de NY-ESO-1 | n2=en:beractant | rel=r_associated | relid=0 | w=5
  210. lymphocytes T cytotoxiques spécifiques du virus --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T cytotoxiques spécifiques du virus | n2=en:beractant | rel=r_associated | relid=0 | w=5
  211. lymphocytes T exprimant le CAR anti-CD22 --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T exprimant le CAR anti-CD22 | n2=en:beractant | rel=r_associated | relid=0 | w=5
  212. lymphocytes T exprimant un CAR spécifique au BCMA --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T exprimant un CAR spécifique au BCMA | n2=en:beractant | rel=r_associated | relid=0 | w=5
  213. lymphocytes T régulateurs du donneur --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T régulateurs du donneur | n2=en:beractant | rel=r_associated | relid=0 | w=5
  214. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée | n2=en:beractant | rel=r_associated | relid=0 | w=5
  215. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique | n2=en:beractant | rel=r_associated | relid=0 | w=5
  216. lymphocytes T à antigènes multiples de précision des cellules dendritiques --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes T à antigènes multiples de précision des cellules dendritiques | n2=en:beractant | rel=r_associated | relid=0 | w=5
  217. lymphocytes autologues thérapeutiques --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes autologues thérapeutiques | n2=en:beractant | rel=r_associated | relid=0 | w=5
  218. lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline | n2=en:beractant | rel=r_associated | relid=0 | w=5
  219. lymphocytes t cytotoxiques spécifiques des taa du lymphome --- r_associated #0: 5 --> en:beractant
    n1=lymphocytes t cytotoxiques spécifiques des taa du lymphome | n2=en:beractant | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr